Kezdőlap・Részvénylista・ResMed Inc

ResMed Inc

Lezárt

SzektorEgészségügy

211.83 -4.93

Vétel Eladás

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

202

Maximum

222.61

Fő mutatók
By Trading Economics
Bevétel	6.1M 399M
Értékesítés	8.6M 1.4B
P/E Szektor átlag	20.731 68.51
Egy részvényre jutó nyereség	2.86
Osztalékhozam	1.1
Profit margin	27.856
Munkavállalók	10,600
EBITDA	17M 584M

Ajánlások
By TipRanks
Ajánlások	Vétel
12 hónapos előrejelzés	+6.57% upside

Osztalékok
By Acuity
Osztalékhozam Szektor átlag	1.10% 2.29%
Következő eredményjelentés	2026. okt. 29.
Következő osztalékfizetési dátum	2026. szept. 24.
Következő korábbi osztalék dátum	2026. aug. 20.

Piaci statisztika
By TradingEconomics
Piaci kapitalizáció	-1.1B 31B
Előző nyitás	216.76
Előző zárás	211.83

ResMed Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 7. 23:41 UTC

News

ResMed shares declined after-market despite RBC Capital raising its price target to $244 and maintaining a Sector Perform rating.

2026. aug. 6. 23:01 UTC

News

ResMed shares declined in after-market trading despite a fourth-quarter earnings beat. The company reported a non-GAAP EPS of $2.95 and revenue of $1.46 billion.

2026. aug. 5. 19:11 UTC

News

ResMed Inc shares are higher as the company prepares for earnings on August 5, 2026, following a quarter that exceeded expectations.

2026. aug. 4. 20:02 UTC

News

ResMed Inc shares are advancing, supported by strong cash flow and global growth. The stock has maintained a notable gain since Monday's close.

2026. aug. 3. 21:02 UTC

News

ResMed Inc. shares are higher in after-market trading, supported by strong financials and a free cash flow margin of 31.7%.

2026. júl. 31. 21:01 UTC

Resmed Inc shares advanced in after-market trading, significantly above their 20-day moving average. No specific news was identified to explain the increase.

2026. júl. 30. 19:55 UTC

ResMed Inc's shares are declining today, diverging from a broader tech recovery. No specific news was identified to explain the move.

2026. júl. 29. 19:04 UTC

ResMed Inc's shares are higher Wednesday, reflecting overall upward momentum since Tuesday's close, despite a recent pullback from session highs.

2026. júl. 28. 19:02 UTC

Shares of Resmed Inc. are higher today, driven by gains in Health Care Equipment stocks. No specific news was identified to explain this increase.

2026. júl. 27. 22:26 UTC

Resmed Inc shares are trading higher in after-hours activity, remaining above their 20-day moving average despite no specific news driving the price movement.

2026. júl. 24. 16:03 UTC

ResMed Inc shares are higher today, driven by gains in the Health Care Equipment sub-sector, despite earlier volatility and recent underperformance.

2026. júl. 22. 23:16 UTC

Resmed Inc shares are trading higher in after-market hours, rebounding from an initial dip and showing unusual strength compared to typical performance.

2026. júl. 21. 20:56 UTC

Resmed Inc. shares are trading roughly flat after-market, amid broader market optimism following positive earnings from 3M and General Motors.

2026. júl. 20. 19:16 UTC

ResMed Inc shares are lower today, continuing a downward trend since Friday. The stock briefly hit a session high earlier but has since declined.

Társak összehasonlítása

Árváltozás

ResMed Inc Előrejelzés

Célár

By TipRanks

6.57% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 237.91 USD 6.57%

Magas 320 USD

Alacsony 213 USD

14 Wall Street elemző 12 hónapos célárain alapulva a(z)ResMed Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

14 ratings

Vétel

Tartás

Eladás

14 Wall Street elemző célárain alapulva a(z)ResMed Inc termékhez az elmúlt 3 hónapban.

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

Rólunk ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.